Haleon Stock - GSK exits remaining stake in consumer health group
18.06.2026 - 22:15:05 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 20:05 UTC. Details in the imprint.
Haleon (GB00BMX86B70) faces a changed shareholder landscape after former parent GSK sold its remaining stake in the consumer health group to institutional investors. The disposal, reported earlier this week by The Economic Times citing deal details, removes a long-standing stock overhang and sharpens focus on Haleon’s standalone valuation.
All news and analysis on Haleon stock
Key figures, news and regulatory documents for Haleon shares can be found in the dedicated topic section and on the company’s investor-relations pages.
GSK completes Haleon stake sale
British drugmaker GSK has raised about GBP 1.25 billion from selling its remaining stake in Haleon via a placing to institutional investors, bringing its ownership to zero according to recent deal reports. The transaction follows earlier staged selldowns since Haleon’s spin-off from GSK in 2022.
The exit removes an overhang that had been closely watched by investors who feared further large blocks hitting the market. With GSK now out, Haleon’s shareholder base is more diversified, and trading in the shares is likely to be driven more by fundamentals than legacy ownership.
Chart picture around key levels
On the London Stock Exchange, Haleon shares recently traded around 332.00p, down 0.78% on the day as of 08:52 BST on 06/18/2026, according to a live quote overview. In New York, the ADR last changed hands near $8.98 on the NYSE in Thursday afternoon trading.
Over the past 12 months, Haleon’s London listing has delivered a negative low-teens percentage performance and trades notably below its 52-week high, data from a German quote service show. The stock, however, remains several percentage points above its 52-week low, indicating some technical support in the lower trading range.
The product engine behind Haleon
Haleon generates revenue from a broad portfolio of over-the-counter consumer health brands, including leading names in oral health, pain relief, respiratory products and vitamins, minerals and supplements such as Sensodyne toothpaste and Voltaren pain gel.
Where the stock trades today
Haleon shares (GB00BMX86B70) trade on the London Stock Exchange at about 332.00p as of 06/18/2026, 08:52 BST.
Key facts on Haleon stock
- Company: Haleon plc
- ISIN: GB00BMX86B70
- WKN: A3DNZQ
- Ticker: HLN
- Venue: London Stock Exchange
- Price (as of 06/18/2026, 08:52 BST): 332.00p GBP
- Market cap: around GBP 33.90 billion (as of 06/18/2026)
- Sector / Industry: Healthcare - Consumer health products
- Index membership: FTSE 100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
